We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Majority of ICD Patients Die of Heart Failure

By HospiMedica International staff writers
Posted on 15 May 2012
Patients with implantable cardiac defibrillators (ICDs) or cardiac resynchronization therapy defibrillators (CRT-Ds) are likelier to die of heart failure (HF), according to a new study.

Researchers at Leiden University Medical Center (LUMC; The Netherlands) conducted a study involving 2,859 patients who underwent an ICD or CRT-D implantation at the LUMC between 1996 and 2010. More...
The patients were divided into primary prevention ICD, secondary prevention ICD, and CRT-D patients. For patients who died during follow-up, the mode of death was retrieved from hospital and general practitioner records, and categorized according to a predetermined classification: HF death, other cardiac death, sudden death, noncardiac death, and unknown death.

The results showed that the cumulative incidence of all-cause mortality increased over time, going from 2% at 2 years to 40% after 8 years. The 8-year cumulative incidence for HF death was 8.6% among patients with an ICD for primary prevention, 9.6% among secondary prevention ICD patients, and 22.6% for those with a CRT-D. Conversely, the 8-year cumulative incidence of sudden death was 2.1% and 3.2% in the primary and secondary prevention ICD patients, and 3.6% in those with a CRT-D; in all, sudden death accounted for approximately 7-8% of all deaths. The most common causes of noncardiac death among the three groups were malignant neoplasm and infection, but there was a large number deaths for which the cause could not be determined. The study was published early online on April 18, 2012, in the journal HeartRhythm.

“For all patients, heart failure and noncardiac death are the most common modes of death,” concluded lead author Martin Schalij, MD, PhD, and colleagues of the department of cardiology. “The proportion of patients who died suddenly was low and comparable for primary and secondary ICD, and CRT-D patients.”
Defibrillator devices have been shown in large randomized trials to decrease mortality among primary prevention ICD patients, including those with ischemic and nonischemic heart disease at risk of sudden arrhythmic death. They also have been shown to have a mortality benefit in secondary prevention, including those who have survived life-threatening ventricular arrhythmias, mainly due to the addition of defibrillation capabilities.

Related Links:

Leiden University Medical Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.